Furthermore, a study on a murine model of pulmonary fibrosis has recently been conducted to evaluate the safety and efficacy of an original PPARγ modulator called GED-0507-34-Levo (GED-0507), in halting or even reversing pulmonary fibrosis induced by bleomycin. Here, PPARG is linked to pulmonary fibrosis.